919
Views
43
CrossRef citations to date
0
Altmetric
Critical Care

Extracorporeal treatment for theophylline poisoning: Systematic review and recommendations from the EXTRIP workgroup

, , , , , , , , & show all
Pages 215-229 | Received 13 Jan 2015, Accepted 29 Jan 2015, Published online: 26 Feb 2015

References

  • Ghannoum M, Nolin TD, Lavergne V, Hoffman RS. Blood purification in toxicology: nephrology's ugly duckling. Adv Chronic Kidney Dis 2011; 18:160–166.
  • Lavergne V, Nolin TD, Hoffman RS, Robert D, Gosselin S, Goldfarb DS, et al. The EXTRIP (Extracorporeal Treatments In Poisoning) workgroup: Guideline methodology. Clin Toxicol 2012; 50:403–413.
  • Ghannoum M, Lavergne V, Nolin TD, Hoffman RS. The utility of extracorporeal treatment for acute thallium poisoning: the first recommendation from the Extracorporeal Treatment in Poisoning Workgroup. Clin Toxicol 2012; 50:574–720.
  • Mactier R, Laliberte M, Mardini J, Ghannoum M, Lavergne V, Gosselin S, et al. Extracorporeal treatment for barbiturate poisoning: recommendations from the EXTRIP Workgroup. Am J Kidney Dis 2014; 64:347–358.
  • Yates C, Galvao T, Sowinski KM, Mardini K, Botnaru T, Gosselin S, et al. Extracorporeal treatment for tricyclic antidepressant poisoning: Recommendations from the EXTRIP Workgroup. Semin Dial 2014; 27:381–389.
  • Gosselin S, Juurlink DN, Kielstein JT, Ghannoum M, Lavergne V, Nolin TD, et al. Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) 2014; 52:856–867.
  • Lavergne V, Ouellet G, Bouchard J, Galvao T, Kielstein JT, Roberts DM, et al. Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial 2014; 27:407–414.
  • Ghannoum M, Yates C, Galvao TF, Sowinski KM, Vo TH, Coogan A, et al. Extracorporeal treatment for carbamazepine poisoning: Systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) 2014; 52:993–1004.
  • Roberts DM, Yates C, Megarbane B, Winchester JF, Maclaren R, Gosselin S, et al. Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Crit Care Med 2015; 43:461–472.
  • Blouin RA, Bauer LA, Bustrack JA, Record KE, Bivins BA. Theophylline hemodialysis clearance. Ther Drug Monit 1980; 2:221–223.
  • Trembath PW, Boobois SW. Pharmacokinetics of a sustained-release theophylline formulation. Br J Clin Pharmacol 1980; 9:365–369.
  • Antoniou T, Gomes T, Mamdani MM, Juurlink DN. Ciprofloxacin-induced theophylline toxicity: a population-based study. Eur J Clin Pharmacol 2011; 67:521–526.
  • Gaudreault P, Guay J. Theophylline poisoning. Pharmacological considerations and clinical management. Med Toxicol 1986; 1: 169–191.
  • Levy G, Koysooko R. Renal clearance of theophylline in man. J Clin Pharmacol 1976; 16:329–332.
  • Jusko WJ, Schentag JJ, Clark JH, Gardner M, Yurchak AM. Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clin Pharmacol Ther 1978; 24:405–410.
  • Hendeles L, Weinberger M, Bighley L. Disposition of theophylline after a single intravenous infusion of aminophylline. Am Rev Respir Dis 1978; 118:97–103.
  • Powell JR, Thiercelin JF, Vozeh S, Sansom L, Riegelman S. The influence of cigarette smoking and sex on theophylline disposition. Am Rev Respir Dis 1977; 116:17–23.
  • Nielsen-Kudsk F, Magnussen I, Jakobsen P. Pharmacokinetics of theophylline in ten elderly patients. Acta Pharmacol Toxicol (Copenh) 1978;42: 226–234.
  • Antal EJ, Kramer PA, Mercik SA, Chapron DJ, Lawson IR. Theophylline pharmacokinetics in advanced age. Br J Clin Pharmacol 1981; 12:637–645.
  • Jenne JW, Wyze MS, Rood FS, MacDonald FM. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 1972; 13:349–360.
  • Chrzanowski FA, Niebergall PJ, Mayock RL, Taubin JM, Sugita ET. Kinetics of intravenous theophylline. Clin Pharmacol Ther 1977; 22:188–195.
  • Greenberg A, Piraino BH, Kroboth PD, Weiss J. Severe theophylline toxicity. Role of conservative measures, antiarrhythmic agents, and charcoal hemoperfusion. Am J Med 1984; 76:854–860.
  • Lelo A, Birkett DJ, Robson RA, Miners JO. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol 1986; 22:177–182.
  • Le Guennec JC, Billon B. Delay in caffeine elimination in breast-fed infants. Pediatrics 1987; 79:264–268.
  • Mowry JB, Spyker DA, Cantilena LR, Jr., Bailey JE, Ford M. 2012 annual report of the American association of poison control centers’ national poison data system (NPDS): 30th annual report. Clin Toxicol (Phila) 2013; 51:949–1229.
  • Litovitz TL, Holm KC, Bailey KM, Schmitz BF. 1991 annual report of the American association of poison control centers national data collection system. Am J Emerg Med 1992; 10:452–505.
  • Mahoori A, Hassani E, Noroozinia H, Javaheri N, Hatami S. Theophylline versus acetaminophen in the treatment of post- dural puncture headache (PDPH). Middle East J Anaesthesiol 2013; 22:289–292.
  • Kapoor S. Theophylline and its direct anti-neoplastic effects. Respir Med 2013; pii: S0954–6111(13)00306–5.
  • Bilasy ME, Oraby MA, Ismail HM, Maklady FA. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures. J Interv Cardiol 2012; 25: 404–410.
  • Lawyer C, Aitchison J, Sutton J, Bennett W. Treatment of theophylline neurotoxicity with resin hemoperfusion. Ann Intern Med 1978; 88:516–517.
  • Perrin C, Debruyne D, Lacotte J, Laloum D, Bonte JB, Moulin M. Treatment of caffeine intoxication by exchange transfusion in a newborn. Acta Paediatr Scand 1987; 76:679–681.
  • Eldridge FL, Paydarfar D, Scott SC, Dowell RT. Role of endogenous adenosine in recurrent generalized seizures. Exp Neurol 1989; 103:179–185.
  • Shannon M, Lovejoy FH, Jr. Effect of acute versus chronic intoxication on clinical features of theophylline poisoning in children. J Pediatr 1992; 121:125–130.
  • Shannon M. Life-threatening events after theophylline overdose: a 10-year prospective analysis. Arch Intern Med 1999; 159:989–994.
  • Shannon M. Hypokalemia, hyperglycemia and plasma catecholamine activity after severe theophylline intoxication. J Toxicol Clin Toxicol 1994; 32:41–47.
  • Parr MJ, Anaes FC, Day AC, Kletchko SL, Crone PD, Rankin AP. Theophylline poisoning—a review of 64 cases. Intensive Care Med 1990; 16:394–398.
  • Shannon M. Predictors of major toxicity after theophylline overdose. Ann Intern Med 1993; 119:1161–1167.
  • Covelli HD, Knodel AR, Heppner BT. Predisposing factors to apparent theophylline-induced seizures. Ann Allergy 1985; 54: 411–415.
  • Jacobs MH, Senior RM, Kessler G. Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity. JAMA 1976; 235:1983–1986.
  • Olson KR, Benowitz NL, Woo OF, Pond SM. Theophylline overdose: acute single ingestion versus chronic repeated overmedication. Am J Emerg Med 1985; 3:386–394.
  • Hendeles L, Bighley L, Richardson RH, Hepler CD, Carmichael J. Frequent toxicity from IV aminophylline infusions in critically ill patients. Drug Intell Clin Pharm 1977; 12:11–18.
  • Burkle WS, Gwizdala CJ. Evaluation of “toxic” serum theophylline concentrations. Am J Hosp Pharm 1981; 38:1164–1166.
  • Zwillich CW, Sutton FD, Neff TA, Cohn WM, Matthay RA, Weinberger MM. Theophylline-induced seizures in adults. Correlation with serum concentrations. Ann Intern Med 1975; 82: 784–787.
  • Sessler CN. Theophylline toxicity: clinical features of 116 consecutive cases. Am J Med 1990; 88:567–576.
  • Hall KW, Dobson KE, Dalton JG, Ghignone MC, Penner SB. Metabolic abnormalities associated with intentional theophylline overdose. Ann Intern Med 1984; 101:457–462.
  • Bertino JS, Jr., Walker JW. Reassessment of theophylline toxicity. Serum concentrations, clinical course, and treatment. Arch Intern Med 1987; 147:757–760.
  • Aitken ML, Martin TR. Life-threatening theophylline toxicity is not predictable by serum levels. Chest 1987; 91:10–14.
  • Witkowski AA, Meert KL, Sarnaik AP. Management of theophylline poisoning in children. Int Pediatr 1998; 13:98–101.
  • Hoffman RJ. Methylxanthines and Selective B2 Adrenergic Agonists. In: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum N, editors. Goldfrank's toxicologic emergencies, 9th edition. 65. New York: McGraw-Hill Professional; 2011. p. 952–964.
  • Perry H. Theophylline poisoning 2014 [cited2014 September 30]. Available from: http://www.uptodate.com/contents/theophylline-poisoning?source = search_result & search = theophylline&selectedTitle = 6∼150.
  • Henderson A, Wright DM, Pond SM. Management of theophylline overdose patients in the intensive care unit. Anaesth Intensive Care 1992; 20:56–62.
  • Berlinger WG, Spector R, Goldberg MJ, Johnson GF, Quee CK, Berg MJ. Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther 1983; 33:351–354.
  • Vale J, Krenzelok EP., Barceloux VD. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.J Toxicol Clin Toxicol 1999; 37:731–751.
  • Mahutte CK, True RJ, Michiels TM, Berman JM, Light RW. Increased serum theophylline clearance with orally administered activated charcoal. Am Rev Respir Dis 1983; 128:820–822.
  • True RJ, Berman JM, Mahutte CK. Treatment of theophylline toxicity with oral activated charcoal. Crit Care Med 1984; 12: 113–114.
  • Amitai Y, Lovejoy FH, Jr. Characteristics of vomiting associated with acute sustained release theophylline poisoning: Implications for management with oral activated charcoal. J Toxicol Clin Toxicol 1987; 25:539–554.
  • Sessler CN, Glauser FL, Cooper KR. Treatment of theophylline toxicity with oral activated charcoal. Chest 1985; 87:325–329.
  • Fountain J. Theophylline. Toxinz www.toxinz.com. Last accessed 2/13/2015.
  • 2.0 M. Theophylline: Truven Health Analytics Inc; 2014 [cited 2014 September 19]. Available from: http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/evidencexpert/ND_PR/evidencexpert/CS/09FAA1/ND_AppProduct/evidencexpert/DUPLICATIONSHIELDSYNC/606291/ND_PG/evidencexpert/ND_B/evidencexpert/ND_P/evidencexpert/PFActionId/evidencexpert.IntermediateToDocumentLink?. Accessed 13th February 2015.
  • Hymel G. Theophylline toxicity. 2013 [cited Sept 30th 2014]. In: Medscape [Internet]. New York, [cited September 30th 2014]. Available from: http://emedicine.medscape.com/article/818847-overview. Accessed 13th February 2015.
  • Wikitox. Theophylline. 2.1.11.4.8.2. Available from: http://curriculum.toxicology.wikispaces.net/2.1.11.4.8.2 + Theophylline. Accessed 13th February 2015.
  • Appraisal of guidelines for research, evaluation. AGREE instrument. London: The AGREE Collaboration; 2001.
  • Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328:1490.
  • Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, USA: RAND; 2011. Available from: http://www.rand.org/.
  • Woo OF, Pond SM, Benowitz NL, Olson KR. Benefit of hemoperfusion in acute theophylline intoxication. J Toxicol Clin Toxicol 1984; 22:411–424.
  • Park GD, Spector R, Roberts RJ, Goldberg MJ, Weismann D, Stillerman A, Flanigan MJ. Use of hemoperfusion for treatment of theophylline intoxication. Am J Med 1983; 74:961–966.
  • Shannon MW. Comparative efficacy of hemodialysis and hemoperfusion in severe theophylline intoxication. Acad Emerg Med 1997; 4:674–678.
  • Kennedy HJ, Greaves M, Triger DR. Clinical experience with the use of charcoal haemoperfusion: is prostacyclin required? Life Support Syst 1985; 3:115–122.
  • Gaudreault P, Wason S, Lovejoy FH, Jr. Acute pediatric theophylline overdose. Clinical severity, pharmacokinetics and treatment in 28 patients. Vet Hum Toxicol 1982; 24:282.
  • Acikalin A, Gulen M, Kosenli O, Topal M. Theophylline poisoning: haemodialysis or haemoperfusion. Akademik Acil Tip Olgu Sunumlari Dergisi 2011; 2:39–41.
  • Ahlmen J, Heath A, Herlitz H, Kvist L, Mellstrand T. Treatment of oral theophylline poisoning. Acta Med Scand 1984; 216: 423–426.
  • Alvan G, Asaba H, Bergstrom J. Acute theophylline intoxication treated with hemoperfusion in combination with hemodialysis. Lakartidningen 1982; 79:745–746.
  • Baldwin LN, Henderson A, Potter JM. Theophylline poisoning in an elderly woman mistaken for acute myocardial infarction. Clin Intensive Care 1993; 4:73–74.
  • Barazarte V, Rodriguez Z, Ceballos S, Espinoza OB, Irastorza IM, Ramirez MS. Exchange transfusion in a case of severe theophylline poisoning. Vet Hum Toxicol 1992; 34:524.
  • Bentur Y, Singer P, Hoffer E, Aloufy A. Charcoal hemoperfusion in theophylline poisoning. Harefuah 1987; 113:106–108.
  • Besbas N, Ozcelik U, Soylemezoglu O, Saatci U, Bakkaloglu A. Hemoperfusion treatment in theophylline toxicity: a case report. Cocuk Sagligi ve Hastaliklari Dergisi 1993; 36:259–262.
  • Biberstein MP, Ziegler MG, Ward DM. Use of beta-blockade and hemoperfusion for acute theophylline poisoning. West J Med 1984; 141:485–490.
  • Bouffard J, Lardet G, Tissot S, Perrot D, Delafosse B, Motin J. Theophylline intoxication: toxicokinetic evaluation of hemodialysis. Intensive Care Med 1993; 19:122.
  • Brubacher JR, Levine B, Hoffman RS. Intestinal pseudo-obstruction (Ogilvie's syndrome) in theophylline overdose. Vet Hum Toxicol 1996; 38:368–370.
  • Buckley BM, Braithwaite RA, Vale JA. Theophylline poisoning. Lancet 1983; 2:618.
  • Burgess E, Sargious P. Charcoal hemoperfusion for theophylline overdose: case report and proposal for predicting treatment time. Pharmacotherapy 1995; 15:621–624.
  • Chang TM, Espinosa-Melendez E, Francoeur TE, Eade NR. Albumin-collodion activated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year-old patient. Pediatrics 1980; 65:811–814.
  • Colonna F, Trappan A, de Vonderweid U, Nisi G. Peritoneal dialysis in a 6-weeks old preterm infant with severe theophylline intoxication. Minerva Pediatr 1996; 48: 383–385.
  • Connell JM, McGeachie JF, Knepil J, Thomson A, Junor B. Self-poisoning with sustained-release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusion. Br Med J (Clin Res Ed) 1982; 284:943.
  • Devaux AM, Leluyer B, Corbery F, Pierre G, Ensel P. Massive theophylline poisoning in a child. Value of extrarenal dialysis. Presse medicale (Paris, France:1983). 1983; 12:1998–1999.
  • Drent M, Kuks PF, van den Bosch JM, Brandt KH. Psychiatric symptoms due to theophylline overdose; the necessity of blood level monitoring. Ned Tijdschr Geneeskd 1993; 137:1831–1835.
  • Ehlers SM, Zaske DE, Sawchuk RJ. Massive theophylline overdose. Rapid elimination by charcoal hemoperfusion. JAMA 1978; 240:474–475.
  • Ferner RE, Pottage A, Ryan DW, Bateman DN. Charcoal-column haemoperfusion does not significantly enhance chlormethiazole removal. Hum Toxicol 1986; 5:367–368.
  • Filejski W, Kurowski V, Batge B, Mentzel H, Djonlagic H. The clinical course and therapy of massive theophylline poisoning. Dtsch Med Wochenschr 1993; 118:1641–1646.
  • Gallagher EJ, Howland M, Greenblatt H. Hemolysis following treatment of theophylline overdose with coated charcoal hemoperfusion. J Emerg Med 1987; 5:19–22.
  • Gitomer JJ, Khan AM, Ferris ME. Treatment of severe theophylline toxicity with hemodialysis in a preterm neonate. Pediatr Nephrol 2001; 16:784–786.
  • Gordjani N, Burghard R, Leititis JU, Brandis M, Puschel CH, Gundert-Remy U. Acute intoxication with theophylline, proxyphylline and diprophylline in a 3-month-old infant after rectal application: pharmacokinetic data under hemoperfusion. Acta Paediatr Scand 1990; 79:112–114.
  • Gundert-Remy U, Krudewagen B, Hildebrandt R. Plasma concentrations of theophylline and its metabolites in a theophylline intoxicated child - Reevaluation of published K(m)-values. Br J Clin Pharmacol 1986; 22:617–618.
  • Henderson A, Pond SM. Rapid rise in serum theophylline concentration after overdose with sustained release theophylline. Med J Aust 1992; 157:354– 356.
  • Henderson JH, McKenzie CA, Hilton PJ, Leach RM. Continuous venovenous haemofiltration for the treatment of theophylline toxicity. Thorax 2001; 56:242–243.
  • Higgins RM, Hearing S, Goldsmith DJ, Keevil B, Venning MC, Ackrill P. Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis? Postgrad Med J 1995; 71:224–226.
  • Hootkins R, Sr., Lerman MJ, Thompson JR. Sequential and simultaneous “in series” hemodialysis and hemoperfusion in the management of theophylline intoxication. J Am Soc Nephrol 1990; 1:923–926.
  • Itoh Y, Nagaki S, Kuyama N, Hirano K, Sunahara M, Funatsuka M, et al. A case of acute theophylline intoxication with repeated status convulsivus. No To Hattatsu 1999; 31:559–564.
  • Jefferys DB, Raper SM, Helliwell M, Berry DJ, Crome P. Haemoperfusion for theophylline overdose. Br Med J 1980; 280:1167.
  • Jira PE, Semmekrot BA, Vree TB, Monnens LAH. Theophylline intoxication in children. Ned Tijdschr Geneeskd 1996; 140: 1608–1611.
  • Kelly WJ, Parkin WG. Charcoal hemoperfusion treatment of severe theophylline toxicity. Aust N Z J Med 1985; 15:75–77.
  • Kingston R, Davin T, Soxena K, Zola E. Theophylline toxicity: charcoal hemoperfusion. Vet Hum Toxicol 1982; 24:284.
  • Kneser J, Wehmeier P, Lichtinghagen R, Hoeper MM, Kielstein JT. Successful treatment of life threatening theophylline intoxication in a pregnant patient by hemodialysis. Clin Nephrol 2013; 80:72–74.
  • Koeijers JJ, Verhoeven CL, Boersma HH, van Mook WNKA. Treatment of theophylline intoxication using continuous venovenous haemofiltration. Neth J Crit Care 2008; 12:32–34.
  • Korsheed S, Selby NM, Fluck RJ. Treatment of severe theophylline poisoning with the molecular adsorbent recirculating system (MARS). Nephrol Dial Transplant 2007; 22:969–970.
  • Kretz M, Fischbach M, Simeoni U, Farge A, Burtscher A, Geisert J, et al. Severe theophylline poisoning in children. Value of hemodialysis with high permeability membrane. Arch Fr Pediatr 1988; 45:821–822.
  • Krishna GG, Zahrowski JJ, Nissenson AR. Hemodialysis for theophylline overdose. Dialysis Transplant 1983;12:40.
  • Kukes VG, Tsoy AN, Gavrilenko LN, Bogovsky BP, Stefadu JG. Comparative study of methods for active theophylline removal. Eur J Pharmacol 1990; 183:2373.
  • Kurczabinska-Lubon D, Nowicka M, Stoltny L, Lubon D, Lubina A, Karpel E. Haemofiltration for severe suicidal theophylline poisoning. Case reportAnestezjol Intens Ter 2005; 37:251–254.
  • Laggner AN, Kaik G, Lenz K, Druml W, Kleinberger G. Treatment of severe poisoning with slow release theophylline. Br Med J (Clin Res Ed) 1984; 288:1497.
  • Laussen P, Shann F, Butt W, Tibballs J. Use of plasmapheresis in acute theophylline toxicity. Crit Care Med 1991; 19:288–290.
  • Leventhal LJ, Kochar G, Feldman NH, Podolsky SM, Stanek MS. Lactic acidosis in theophylline overdose. Am J Emerg Med 1989; 7:417–418.
  • Lim S, Tan SH, Ng TG, Tai DYH. Successful treatment of theophylline toxicity with continuous venovenous haemofiltration. Crit Care Shock 2005; 8:96–97.
  • Lim TK, Tan CC. Treatment of severe theophylline toxicity with oral activated charcoal and haemodialysis—a case report. Singapore Med J 1988; 29:601–603.
  • Lin JL, Lim PS. Continuous arteriovenous hemoperfusion in acute poisoning. Blood Purif 1994; 12:121–127.
  • Liu PH, Lee BJ, Wang CY, Hung DZ. Acute pancreatitis after severe theophylline overdose. Clin Toxicol 2008; 46:1103.
  • Lopez Puerta JJ, Homs Gimeno CA, Perez Llorens JC, Luque Gomez P, Celaya Perez S, Pardo Camacho F. Theophylline intoxication treated by charcoal hemoperfusion. Med Intensiva 1994; 18:44–45.
  • Lynn KL, Buttimore AL, Begg EJ, Gordon GS. Treatment of theophylline poisoning with haemoperfusion. N Z Med J 1988; 101:4–5.
  • MacDonald JB, Jones HM, Cowan RA. Rhabdomyolysis and acute renal failure after theophylline overdose. Lancet 1985; 1:932–933.
  • Majek M, Volnarova A, Holla Z, Lichvarova I, Valaska P. Acute theophylline intoxication - case report. Anesteziol Intenziv Med 2008; 19:197–202.
  • Miceli JN, Bidani A, Aronow R. Peritoneal dialysis of theophylline. Clin Toxicol 1979; 14:539–544.
  • Miceli JN, Clay B, Fleischmann LE, Sarnaik AP, Aronow R, Done AK. Pharmacokinetics of severe theophylline intoxication managed by peritoneal dialysis. Dev Pharmacol Ther 1980; 1:16–25.
  • Modi KB, Horn EH, Bryson SM. Theophylline poisoning and rhabdomyolysis. Lancet 1985; 2:160–161.
  • Molby L, Kruhoffer PK. Hemoperfusion in theophylline poisoning. Ugeskr Laeger 1991; 153:2363–2364.
  • Montoya-Cabrera MA, Lopez-Martin G, Hernandez-Zamora A. Treatment of aminophylline poisoning according to its pharmacologic properties. Gac Med Mex 1984; 120:347–350.
  • Mydlik M, Derzsiova K, Smolko P, Petrikova V, Vzentekova T. Hemoperfusion with Amberlite XAD-4 in acute theophylline poisoning. Cas Lek Cesk 1995; 134:145–146.
  • Nogue S, Nadal P, Torra M, Mangues MA. Effectiveness of hemodialysis in severe theophylline toxicity. Med Intensiva 1994; 18: 133–134.
  • Okada S, Teramoto S, Matsuoka R. Recovery from theophylline toxicity by continuous hemodialysis with filtration. Ann Intern Med 2000; 133:922.
  • Osborn HH, Henry G, Wax P, Hoffman R, Howland MA. Theophylline toxicity in a premature neonate—elimination kinetics of exchange transfusion. J Toxicol Clin Toxicol 1993; 31:639–644.
  • Powell B. A complex self-poisoning. CME J Geriatr Med 2001; 3:29–31.
  • Price L. Treatment of theophylline overdose using hemoperfusion. ANNA J 1987; 14:227–232.
  • Raper S, Crome P, Vale A, Helliwell M, Widdop B. Experience with activated carbon-bead haemoperfusion columns in the treatment of severe drug intoxication. A preliminary report. Arch Toxicol 1982; 49:303–310.
  • Reyes GM, Frutos Sanz MA, Aranda Lara P. Severe theophylline intoxication treated with charcoal hemoperfusion. Nefrologia 1986; 6:95–98.
  • Rietveld AP, Diderich PP. A patient with severe theophylline poisoning. Ned Tijdschr Geneeskd 1985; 129:1741–1743.
  • Roca A, Lens XM, Pastor A, Pascual R. Theophylline poisoning: use of hemoperfusion with activated charcoal. Rev Clin Esp 1988; 182:392–393.
  • Rongved G, Westlie L. Hemoperfusion/hemodialysis in the treatment of acute theophylline poisoning—description of a fatal case. Int J Clin Pharmacol Ther Toxicol 1986; 24:85–87.
  • Rothman A, Sessler CN. Management of theophylline toxicity. Va Med 1985; 112:504–508.
  • Russo ME. Management of theophylline intoxication with charcoal-column hemoperfusion. N Engl J Med 1979; 300:24–26.
  • Rutten J, van den Berg B, van Gelder T, van Saase J. Severe theophylline intoxication: a delay in charcoal haemoperfusion solved by oral activated charcoal. Nephrol Dial Transplant 2005; 20: 2868–2869.
  • Sahney S, Abarzua J, Sessums L. Hemoperfusion in theophylline neurotoxicity. Pediatrics 1983; 71:615–619.
  • Schwartz MP, Taylor AT. Multi-drug theophylline overdose. J Fam Pract 1989; 28:575–577.
  • Seneff M, Scott J, Friedman B, Smith M. Acute theophylline toxicity and the use of esmolol to reverse cardiovascular instability. Ann Emerg Med 1990; 19:671–673.
  • Shankar PS, Scott JH, Anderson CL. Charcoal haemodetoxification for theophylline toxicity. Indian J Chest Dis Allied Sci 1981; 23:93–96.
  • Shannon M, Wernovsky G, Morris C. Exchange transfusion in the treatment of severe theophylline poisoning. Pediatrics 1992; 89: 145–147.
  • Shechter P, Berkenstat H, Segal E, Rapoport J. Theophylline intoxication: clinical features and pharmacokinetics during treatment with charcoal hemoperfusion. Isr J Med Sci 1996; 32:766–770.
  • Soto J, Sacristan JA, de Francisco AM, Queipo C. Treatment of theophylline poisoning with hemodialysis. Med Clin (Barc) 1991; 96:115–116.
  • Stegeman CA, Jordans JG. Theophylline intoxication, clinical features, treatment and outcome: a case report and a review of the literature. Neth J Med 1991; 39:115–125.
  • Stegmayr BG. On-line hemodialysis and hemoperfusion in a girl intoxicated by theophylline. Acta Med Scand 1988; 223:565–567.
  • Teweleit S, Hippius M, Pfeifer R, Hoffmann A. Rhabdomyolysis as a rare complication of theophylline poisoning. Med Klin (Munich) 2001; 96:40–44.
  • Titley OG, Williams N. Theophylline toxicity causing rhabdomyolysis and acute compartment syndrome. Intensive Care Med 1992; 18:129–130.
  • Torrabadella P, Tomas R, Tomasa T, Paya JM, Rodriguez-Pazos M. Multiple intoxication with high levels of theophylline treated by hemodyalisis Med Intensiva 1994; 18:42–44.
  • Turk J, Aks SE, Hryhorczuk DO. Constraints on the enhancement of elimination of drugs with activated charcoal. Vet Hum Toxicol 1993; 35:489–495.
  • Uher M, Kurak M, Pisarcikova M, Filka J, Podracka L, Hulikova M, et al. Severe theophylline poisoning in children. Anesteziologie a Neodkladna Pece 2000; 11:125–128.
  • Uprichard AC, Bailie R, McAteer E. Management of severe theophylline overdosage by charcoal haemoperfusion. Ulster Med J 1984; 53:159–161.
  • van Kesteren RG, van Dijk A, Klein SW, van Heijst AN. Massive theophylline intoxication: effects of charcoal haemoperfusion on plasma and erythrocyte theophylline concentrations. Hum Toxicol 1985; 4:127–134.
  • Wisniewski M, Waldman W, Sein Anand J. Continuous venovenous hemodiafiltration in acute theophylline overdose - a case report. Clin Toxicol 2010; 48:248.
  • Yokoyama T. For which cases should clinicians perform blood purification in the management of acute poisoning?Clinical and pharmacological analyses.Chudoku Kenkyu 2004; 17:139–148.
  • Dietrich AM, Mortensen ME. Presentation and management of an acute caffeine overdose. Pediatr Emerg Care 1990; 6:296–298.
  • Gordon SM, Nanagas K, Mowry JB. Caffeine elimination half-life during peritoneal dialysis in a pediatric overdose. Clin Toxicol (Phila) 2004; 42:742.
  • Holstege CP, Hunter Y, Baer AB, Savory J, Bruns DE, Boyd JC. Massive caffeine overdose requiring vasopressin infusion and hemodialysis. J Toxicol Clin Toxicol 2003; 41:1003–1007.
  • Kapur R, Smith MD. Treatment of cardiovascular collapse from caffeine overdose with lidocaine, phenylephrine, and hemodialysis. Am J Emerg Med 2009; 27:253.e3–6.
  • Nagesh RV, Murphy KA, Jr. Caffeine poisoning treated by hemoperfusion. Am J Kidney Dis 1988; 12:316–318.
  • Walsh I, Wasserman GS, Mestad P, Lanman RC. Near-fatal caffeine intoxication treated with peritoneal dialysis. Pediatr Emerg Care 1987; 3:244–249.
  • Zimmerman PM, Pulliam J, Schwengels J, MacDonald SE. Caffeine intoxication: a near fatality. Ann Emerg Med 1985; 14:1227–1229.
  • Anderson JR, Poklis A, McQueen RC, Purtell JN, Slavin RG. Effects of hemodialysis on theophylline kinetics. J Clin Pharmacol 1983; 23:428–432.
  • Brown GS, Lohr TO, Mayor GH, Freitag JJ, Sanchez TV, Prasad JM. Peritoneal clearance of theophylline. Am J Kidney Dis 1981; 1:24–26.
  • Chang DB, Kuo SH, Yang PC, Shen FH, Luh KT. Clearance of theophylline by hemodialysis in one patient with chronic renal failure. Chest 1992; 102:1621–1623.
  • Evseev NG, Gorchakov VD, Didkovskii NA, Treskunov VK, Gavrilenko LN. Effects of hemosorption on pharmacokinetics of massive doses of theophylline in bronchial asthma. Sov Med 1989; 26–28.
  • Fleetham JA, Ginsburg JC, Nakatsu K, Wigle RD, Munt PW. Resin hemoperfusion as treatment for theophylline-induced seizures. Chest 1979; 75:741–742.
  • Kradjan WA, Martin TR, Delaney CJ, Blair AD, Cutler RE. Effect of hemodialysis on the pharmacokinetics of theophylline in chronic renal failure. Nephron 1982; 32:40–44.
  • Kroh UF, Lennartz H. Evaluation and first validation study on a simplified drug dosage algorithm for multiple organ failure patients. Ren Fail 1992; 14:579–585.
  • Leakey TE, Elias-Jones AC, Coates PE, Smith KJ. Pharmacokinetics of theophylline and its metabolites during acute renal failure. A case reportClin Pharmacokinet 1991; 21:400–408.
  • Lee CC, Wang LH, Majeske BL, Marbury TC. Pharmacokinetics of dyphylline elimination by uremic patients. J Pharmacol Exp Ther 1981; 217:340–344.
  • Lee CS, Marbury TC, Perrin JH, Fuller TJ. Hemodialysis of theophylline in uremic patients. J Clin Pharmacol 1979; 19:219–226.
  • Lee CS, Peterson JC, Marbury TC. Comparative pharmacokinetics of theophylline in peritoneal dialysis and hemodialysis. J Clin Pharmacol 1983; 23:274–280.
  • Levy G, Gibson TP, Whitman W, Procknal J. Hemodialysis clearance of theophylline. Jama 1977; 237:1466–1467.
  • Nicot G, Charmes JP, Lachatre G, Sautereau D, Valette JP, Eichler B, et al. Theophylline toxicity risks and chronic renal failure. Int J Clin Pharmacol Ther Toxicol 1989; 27:398–401.
  • Slaughter RL, Green L, Kohli R. Hemodialysis clearance of theophylline. Ther Drug Monit 1982; 4:191–193.
  • Urquhart R, Edwards C. Increased theophylline clearance during hemofiltration. Ann Pharmacother 1995; 29:787–788.
  • Vaziri ND, Barton CH, Ness R, Clark D. Dialysability of theophylline. J Dial 1978; 2:243–249.
  • Vree TB, Martea M, Tiggeler RG, Hekster YA, Hafkenscheid JC. Pharmacokinetics of theophylline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysis. Clin Pharmacokinet 1988; 15:390–395.
  • Wells DH, Ferlauto JJ. Survival after massive aminophylline overdose in a premature infant. Pediatrics 1979; 64:252–253.
  • Emonds AJ, Driessen OM. Treatment of theophylline intoxication: a model study utilizing peritoneal dialysis. Clin Toxicol 1978; 13: 505–511.
  • Arimori K, Hashimoto Y, Nakano M. Pharmacokinetics of theophylline and phenobarbital during peritoneal dialysis compared with intestinal dialysis in rats. Chem Pharm Bull (Tokyo) 1990; 38: 3177–3179.
  • Horton MW, Godley PJ, Moore ES, Fineg J, Gillespie WR. Estimation of theophylline clearance during continuous arteriovenous hemofiltration. Artif Organs 1990; 14:416–420.
  • Davis E, Perez A, McKay C. A novel self-contained hemoperfusion device for the treatment of theophylline overdcose in a swine model. Clin Toxicol (Phila) 2003; 41:695–696.
  • Kroh UF, Dinges GK, Lukasewitz P, Steinhausser WU, Holl TJ, Lennartz H. Elimination of drugs by the new polyamide hemofilter FH77H during various in vitro conditions. Blood Purif 1998; 16:49–56.
  • Mac-Kay MV, Fernandez IP, Herrera Carranza J, Sancez Burson J. An in vitro study of the influence of a drug's molecular weight on its overall (Clt), diffusive (Cld) and convective (Clc) clearance through dialysers. Biopharm Drug Dispos 1995; 16:23–35.
  • Reiter K, Bordoni V, Dall’Olio G, Ricatti MG, Soli M, Ruperti S, et al. In vitro removal of therapeutic drugs with a novel adsorbent system. Blood Purif 2002; 20:380–388.
  • Espinosa-Melendez E, Chang TM. ACAC (albumin-collodion coated activated charcoal) hemoperfusion: in-vitro removal and clearance of theophylline. J Dial 1980; 4:21–29.
  • Laurent D, Guenzet J, Bourin M. Theophylline: a haemoperfusion modelisation. Methods Find Exp Clin Pharmacol 1985; 7: 253–258.
  • Derzsiova K, Mydlik M, Petrikova V, Vzentekova T, Molcanyiova A. Hemoperfusion of theophylline. An in vitro study.Cas Lek Cesk 1991; 130:11–14.
  • Amitai Y, Lovejoy FH, Jr. Hypokalemia in acute theophylline poisoning. Am J Emerg Med 1988;6:214–218.
  • Heath A, Knudsen K. Role of extracorporeal drug removal in acute theophylline poisoning. A review.Med Toxicol Adverse Drug Exp 1987; 2:294–308.
  • Assael BM, Caccamo ML, Gerna M, Latini R, Mandelli M, Marini A, et al. Effect of exchange transfusion on elimination of theophylline in premature neonates. J Pediatr 1977; 91: 331–332.
  • Park GD, Radomski L, Goldberg MJ, Spector R, Johnson GF, Quee CK. Effects of size and frequency of oral doses of charcoal on theophylline clearance. Clin Pharmacol Ther 1983; 34: 663–666.
  • Radomski L, Park GD, Goldberg MJ, Spector R, Johnson GF, Quee CK. Model for theophylline overdose treatment with oral activated charcoal. Clin Pharmacol Ther 1984; 35:402–408.
  • Baker MD. Theophylline toxicity in children. J Pediatr 1986; 109:538–542.
  • Gaudreault P, Wason S, Lovejoy FH, Jr. Acute pediatric theophylline overdose: a summary of 28 cases. J Pediatr 1983; 102:474–476.
  • Helliwell M, Berry D. Theophylline poisoning in adults. Br Med J 1979; 2:1114.
  • Ghannoum M, Bouchard J, Nolin TD, Ouellet G, Roberts DM. Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice. Semin Dial 2014; 27:350–361.
  • Nolke AC. Severe toxic effects from aminophylline and theophylline suppositories in children. J Am Med Assoc 1956; 161:693–697.
  • Ghannoum M, Roberts DM, Hoffman RS, Ouellet G, Roy L, Decker BS, et al. A stepwise approach for the management of poisoning with extracorporeal treatments. Semin Dial 2014; 27:362–370.
  • Struthers AD, Elliott HL, Addis GJ. Self-poisoning with sustained-release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusion. Br Med J (Clin Res Ed) 1982; 284:1709.
  • Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 2008; 74:1327–1334.
  • Bouchard J, Roberts DM, Roy L, Ouellet G, Decker BS, Mueller BA, et al. Principles and operational parameters to optimize poison removal with extracorporeal treatments. Semin Dial 2014; 27:371–380.
  • Mardini J, Lavergne V, Roberts D, Ghannoum M. Case reports of extracorporeal treatments in poisoning: Historical trends. Semin Dial 2014; 27:402–406.
  • Maslov OG, Brusin KM, Kochmashev VF, Sentsov VG. Comparative evaluation of methods of extracorporeal detoxification in acute carbamazepine poisoning. Klinicheskaia Toksikologiia 2011;12.
  • Shalkham AS, Kirrane BM, Hoffman RS, Goldfarb DS, Nelson LS. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis 2006; 48:239–241.
  • Ouellet G, Bouchard J, Ghannoum M, Decker BS. Available extracorporeal treatments for poisoning: overview and limitations. Semin Dial 2014; 27:342–349.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.